コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ulated genes myxovirus resistance gene 1 and 2',5' oligoadenylate synthetase.
2 to be conserved among all known isozymes of 2'-5'-oligoadenylate synthetase.
3 ear the amino terminus of the 9-2 isozyme of 2'-5'-oligoadenylate synthetase.
4 e genes encoding antiviral proteins, such as 2'-5' oligoadenylate synthetases.
5 an isozyme of the medium size class of human 2'-5' oligoadenylate synthetases.
6 te-binding sites of the P69 isozyme of human 2'-5'-oligoadenylate synthetases.
8 The upregulation of endogenous IFN-beta and 2',5'-oligoadenylate synthetase 1 mRNA expression was al
9 ted increased expression of interferon-beta, 2',5'-oligoadenylate synthetase 1, interferon-alpha, and
11 vidence of concerted evolution of paralogous 2'-5' oligoadenylate synthetase 1 genes was obtained in
12 d IFN-stimulated gene expression (tracked by 2'-5'-oligoadenylate synthetase 1 and myxovirus (influen
13 vels and no significant difference in IFNB1, 2'-5'-oligoadenylate synthetase 1, or myxovirus (influen
14 d in all animals with increased intrahepatic 2'5' oligoadenylate synthetase 1 (2OAS-1) messenger RNA
16 ulation and an IFN-inducible antiviral gene, 2',5'-oligoadenylate synthetase 1a (OAS), were determine
18 ISG noted on the microarrays, such as STAT1, 2'5'-oligoadenylate synthetase 2, and ISG15, also suppor
19 ins dsRNA-activated protein kinase (PKR) and 2',5'-oligoadenylate synthetase (2',5'-OAS) were down-re
21 The mRNA for IRF-1, p40, and p69 isoforms of 2'-5' oligoadenylate synthetase (2-5 AS) are detectable,
23 Here we report that one of these targets, 2,5 oligoadenylate synthetase (2,5 OAS), is a mediator o
24 , including those coding for MHC I proteins, 2'-5' oligoadenylate synthetase [2'-5'(A)N], and IFN reg
26 o-IFN-beta was supported by induction of the 2'-5' oligoadenylate synthetase, an indicator of IFN act
27 IFN-responsive genes OAS and ISG54 (encoding 2'-5' oligoadenylate synthetase and an IFN-stimulated ge
28 as well as the effector genes, for example, 2'-5'-oligoadenylate synthetase and myxovirus proteins,
29 ted proteins interferon regulatory factor 1, 2',5'-oligoadenylate synthetase, and double-stranded-RNA
30 randed RNA-dependent protein kinase R (PKR), 2',5'-oligoadenylate synthetase, and Mx1 mRNAs in swine
31 s, including myxovirus resistance protein A, 2',5'-oligoadenylate synthetase, and the IFN-stimulated
32 of mRNA for dsRNA-activated protein kinase, 2'5'-oligoadenylate synthetase, and Toll-like receptor 3
36 trong as that of another IFN-inducible gene, 2'-5' oligoadenylate synthetase, but in contrast to 2'-5
37 ed N-terminal domain with the known forms of 2'-5' oligoadenylate synthetases, but differs completely
39 HC class I, IFN regulatory factor-1, MxA and 2',5-oligoadenylate synthetase gene expression, transcri
45 ude the demonstration that the gene encoding 2'-5'oligoadenylate synthetase is responsible for murine
46 ated Gene 15 (ISG15), Interleukin 16 (IL16), 2',5'-Oligoadenylate Synthetase Like (OASL), and Adhesio
47 novel murine cDNA encoding an ovary-specific 2',5'-oligoadenylate synthetase-like protein, OAS1D, whi
51 ding inflammatory (S100A8/A9/A12, CXCL1, and 2'-5'-oligoadenylate synthetase-like [OASL]) and barrier
53 70-fold and myxovirus resistance gene 1 and 2',5' oligoadenylate synthetase mRNA expression (107- an
54 ed genes for IFN-regulatory factors 1 and 7, 2'5' oligoadenylate synthetase, Mx, and TNF superfamily
55 protein 10, and preferential upregulation of 2',5'-oligoadenylate synthetase, Mx1, and indoleamine 2,
56 nown interferon-stimulated genes such as the 2'5'-oligoadenylate synthetase, MX1, IRF-7, and toll-lik
57 o lack of nitric oxide synthase 2 (NOS2) and 2', 5' oligoadenylate synthetase (OAS) 1 induction in re
58 acokinetics, pharmacodynamic measurements of 2',5'-oligoadenylate synthetase (OAS) activity, and indu
60 h the wild-type (WT) virus uses to block the 2',5'-oligoadenylate synthetase (OAS)-RNase L (RNase L)
61 ivity, which blocks the interferon inducible 2',5'-oligoadenylate synthetase (OAS)-RNase L pathway to
62 luding Myxovirus resistance protein 2 (Mx2), 2',5'-oligoadenylate synthetase (OAS-1), Virus inhibitor
63 2-5A is produced by interferon-inducible 2',5'-oligoadenylate synthetases (OAS) upon activation b
64 RNA-dependent protein kinase (PKR), but not 2',5'-oligoadenylate synthetases (OAS), in vaginal tissu
65 on, the eIF2alpha protein kinase PKR and the 2'-5' oligoadenylate synthetase (OAS) are both activated
68 influenza virus resistance allele Mx(+) and 2'-5' oligoadenylate synthetase (OAS) proteins was not r
69 d cDNAs, including inhibitor of apoptosis-1, 2'-5' oligoadenylate synthetase (OAS), a 2'-5' OAS-like
70 fter CpG and correlated with serum levels of 2'-5' oligoadenylate synthetase (OAS), a validated inter
71 antiviral interferon-stimulated gene product 2'-5' oligoadenylate synthetase (OAS), and the chemokine
72 h includes conventional poly(A) polymerases, 2'-5' oligoadenylate synthetase (OAS), and yeast Trf4p .
73 nes (ISGs) with antiviral properties such as 2'-5' oligoadenylate synthetase (OAS), stimulated trans-
74 NA-responsive defenses controlled by PKR and 2'-5' oligoadenylate synthetase (OAS), which respectivel
82 ation in the gene encoding the 1b isoform of 2'-5'-oligoadenylate synthetase (OAS), a member of the O
83 ms of IL-29 and IFN-alpha induced equivalent 2'5' oligoadenylate synthetase (OAS) and MX1 gene expres
84 106 (+/-63.3) pg/ml increase (P < 0.01); and 2'5'-oligoadenylate synthetase (OAS) had a 163 (+/-120.6
86 elevation of the IFN-induced antiviral gene 2',5'-oligoadenylate synthetase (OAS1a) but not dsRNA-de
88 kinase (PKR) and the endoribonuclease of the 2',5'-oligoadenylate synthetase-RNase L system (PKR(-/-)
89 clease component of the interferon-regulated 2',5'-oligoadenylate synthetase-RNase L system, demonstr
90 bsence of IFN-stimulated antiviral proteins, 2'-5' oligoadenylate synthetase/RNase L, and dsRNA-depen
91 in the light of both this new member and new 2'-5' oligoadenylate synthetase sequence data from other
92 ligoadenylate synthetase, but in contrast to 2'-5' oligoadenylate synthetase, TP/PD-ECGF mRNA levels
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。